Deal volume in 2026 is substantially outpacing last year, and activity is being driven by interest in cancer and autoimmune ...
TO caught up with Toronto's own Lilly Singh at Departure Festival, and the homegrown entertainer had plenty to say about the ...
Eli Lilly's new oral weight-loss drug, Foundayo, was prescribed 7,335 times in the ‌U. in the fourth week, a modest uptake ...
Valuation concerns: Eli Lilly trades at a premium P/E multiple versus peers, prompting some investors to search for better-valued opportunities. Novo’s pill momentum: Novo Nordisk’s new GLP-1 pill has ...
There's a reason the world's most patient investors love dividend stocks. Market movements heavily influence a stock's ...
Danish pharma giant Novo Nordisk saw a 70% volume jump for Wegovy in April 2026 after slashing prices by up to 48% to counter ...
The two companies with the steepest increases market blockbuster medications that saw deep price cuts in 2026.
The Indianapolis-based company expanded its spend to ensure it can meet growing demand for genetic therapies and weight-loss ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Gov. Mike Braun, alongside Eli Lilly and Company leaders and employees, on Wednesday celebrated the opening of Lilly Lebanon ...
Eli Lilly could appeal to both growth and income-oriented investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results